Jacobs Levy Equity Management »

Atea Pharmaceuticals shares owned by Jacobs Levy Equity Management

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by Jacobs Levy Equity Management from 13F filings

Historical chart of Jacobs Levy Equity Management investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by Jacobs Levy Equity Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by Jacobs Levy Equity Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.7M 510k 3.35
2024-06-30 $1.9M 565k 3.31
2024-03-31 $2.7M 673k 4.04
2023-12-31 $1.7M 551k 3.05
2023-09-30 $1.7M 553k 3.00
2023-06-30 $2.1M 565k 3.74
2023-03-31 $2.1M 632k 3.35
2022-12-31 $2.4M 499k 4.81
2022-09-30 $2.2M 381k 5.69
2022-06-30 $3.1M 432k 7.10
2022-03-31 $1.1M 154k 7.22